SanticxisSanticxisHealth Economics Advisory

In reimbursement decisions, the question is not only whether an intervention creates value. Decision-makers also need to know whether that value can be funded without destabilizing available budgets.

An innovation can be valuable without being immediately affordable

A health technology may deliver real clinical benefit and present a favorable cost-effectiveness profile. Yet if adoption creates excessive short-term budget pressure, the decision may remain difficult.

Budget impact analysis addresses this concern directly. It translates an adoption strategy into concrete financial consequences for an organization, payer, or health system.

Payers first need clarity

A strong budget impact model does more than calculate additional expenditure. It clarifies the target population, adoption pace, avoided costs, substitution effects, and uncertainty around each scenario.

This clarity is strategic: it helps decision-makers distinguish apparent cost from the expected net impact.

Scenarios make the discussion more robust

Funding decisions are rarely made under perfect certainty. Low, central, and high scenarios help explore the consequences of different adoption assumptions.

This gives the dossier greater credibility because it shows that budget risks have been anticipated rather than reduced to a single fragile number.

Key parameters must be defensible

The quality of a budget impact analysis often depends on a limited set of parameters: eligible population size, expected market share, treatment duration, unit costs, follow-up costs, and potential avoided costs.

When these parameters are documented, sourced, and tested, the analysis becomes more than an accounting exercise. It becomes a decision-support tool able to withstand questions from committees, finance teams, and public payers.

Budget impact should remain connected to the care pathway

A persuasive analysis does not only reason in expenditure lines. It connects costs to the realities of the care pathway: diagnosis, treatment initiation, monitoring, avoided events, hospitalizations, visits, or workforce implications.

This connection to practice prevents the model from becoming abstract. It helps decision-makers understand where costs arise, where savings may emerge, and which conditions make adoption realistic.

Turning affordability into a strategic advantage

For innovators, demonstrating affordability is not a defensive exercise. It shows that an innovation can be integrated with discipline, method, and responsibility.

Santicxis supports organizations in building clear, robust budget impact analyses that can be used directly in payer and decision-maker discussions.

Go further

Related articles, services, and case studies

Economic evaluation

Why economic evaluation is becoming a governance lever in healthcare

From constrained budgets to growing accountability demands, economic evaluation is no longer optional: it structures decision-making.

Read the article
Market access

Market access: what decision-makers actually expect from a strong dossier

Evidence quality, local context, and clarity of positioning often make the difference.

Read the article
Services

Connect analysis to an operational decision

Explore offers related to economic evaluation, reimbursement, market access, HTA, and health economics training.

Explore our services
Turn analysis into decision

Would you like to apply this thinking to your organization, dossier, or strategy?

Santicxis supports governments, industry teams, institutions, and health partners with defensible analysis, clear strategic framing, and decision-ready deliverables.